IP Library Granted Patent US 10,351,551
Granted Patent B2
US 10,351,551 · App. 15/817,561 · Granted Jul 16, 2019

Fluorescent compounds

Inventors: Greg Hermanson (Loves Park, IL); Peter T. Czerney (Weimar, DE); Surbhi Desai (Rockford, IL); Matthias S. Wenzel (Jena, DE); Boguslawa Dworecki (Rockford, IL); Frank G. Lehmann (Jena, DE)
Assignees: Pierce Biotechnology, Inc.; Dyomics GmbH
C07D403/06C07D209/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,351,551
App. No.
15/817,561
Granted
Jul 16, 2019
Kind
B2
Abstract

Compounds used as labels with properties comparable to known fluorescent compounds. The compounds can be conjugated to proteins and nucleic acids for biological imaging and analysis. Synthesis of the compounds, formation and use of the conjugated compounds, and specific non-limiting examples of each are provided.

Claims (14)

1. A compound of general formula I

where

each of R 1 and R 2 is sulfoalkyl;

X is selected from the group consisting of -NETS (hydroxysuccinimidyl), -O-TFP (2,3,5,6-tetrafluorophenoxy), -NR-L-maleimide and combinations thereof where R is —H or an aliphatic or heteroaliphatic group, and L is selected from the group consisting of a divalent linear, crossed, and cyclic alkyl group optionally substituted by at least one oxygen atom and/or sulfur atom;

Kat is one or more cations necessary to balance the negative charge of the compound;

m is 0; o is 3; and n is 1, 2 or 3,

conjugated to a biomolecule selected from at least one of a protein, antibody, enzyme, nucleoside triphosphate, oligonucleotide, biotin, hapten, cofactor, lectin, antibody binding protein, carotenoid, hormone, neurotransmitter, growth factor, toxin, biological cell, lipid, receptor binding drug, organic polymer carrier material, or inorganic polymeric carrier material.

2. A method of labeling at least one biomolecule, the method comprising providing a composition comprising at least one excipient and the compound of claim 1 in an effective concentration to bind to at least one biomolecule, resulting in the compound of claim 1 being bound to the at least one biomolecule.

3. The method of claim 2 wherein the biomolecule is selected from the group consisting of a protein, antibody, enzyme, nucleoside triphosphate, oligonucleotide, biotin, hapten, cofactor, lectin, antibody binding protein, carotenoid, hormone, neurotransmitter, growth factors, toxin, biological cell, lipid, receptor binding drug, fluorescent proteins, organic polymer carrier material, or inorganic polymeric carrier material.

4. A method of detecting at least one biomolecule, the method comprising providing a composition comprising at least one excipient and the compound of claim 1 in an effective concentration to bind to at least one biomolecule, resulting in the compound of claim 1 being bound to the at least one biomolecule, and detecting the biomolecule-bound compound.

5. The method of claim 4 wherein the biomolecule is selected from a protein, antibody, enzyme, nucleoside triphosphate, oligonucleotide, biotin, hapten, cofactor, lectin, antibody binding protein, carotenoid, hormone, neurotransmitter, growth factors, toxin, biological cell, lipid, receptor binding drug, fluorescent proteins, organic polymer carrier material, or inorganic polymeric carrier material.

6. The method of claim 4 wherein the at least one biomolecule is detected in an assay selected from fluorescence microscopy, flow cytometry, in vivo imaging, immunoassay, hybridization, chromatographic assay, electrophoretic assay, microwell plate based assay, fluorescence resonance energy transfer (FRET) system, high throughput screening, or microarray.

7. The method of claim 4 wherein when the biomolecule is detected by in vivo imaging, the method comprises providing the biomolecule-bound compound to at least one of a biological sample, tissue, or organism, and detecting the biomolecule within the at least one of a biological sample, tissue, or organism.

8. A kit for performing an assay to detect at least one biomolecule in a sample, the kit comprising the compound of claim 1 and at least one excipient, and instructions for use.

Assignments (2)
MERGER Recorded Mar 11, 2026
From: PIERCE BIOTECHNOLOGY, INC.
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 075052/0213 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2019
From: HERMANSON, GREG; CZERNEY, PETER T.; DESAI, SURBHI; WENZEL, MATTHIAS S.; DWORECKI, BOGUSLAWA; LEHMANN, FRANK G.
To: PIERCE BIOTECHNOLOGY, INC.; DYOMICS GMBH
Reel/Frame 050676/0773 →
Continuity (6)
Continuation 13330993 · Dec 20, 2011
Provisional Application 61425446 · Dec 21, 2010
Provisional Application 61446319 · Feb 24, 2011
Provisional Application 61480840 · Apr 29, 2011
Provisional Application 61482933 · May 5, 2011
Related Publication 20180118723A1 · May 3, 2018